Trial · NCT02128958
Results by group96
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 96
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Subjects With Overall Survival | CF102 | 12-month Survival - Yes | 16 | Participants | |
| Number of Subjects With Overall Survival | Placebo Tablets of CF102 | 12-month Survival - Yes | 4 | Participants | |
| Number of Subjects With Overall Survival | CF102 | 12-month Survival - No | 34 | Participants | |
| Number of Subjects With Overall Survival | Placebo Tablets of CF102 | 12-month Survival - No | 24 | Participants | |
| Time to Progression (TTP) | CF102 | 5.1 | Inter-Quartile Range 1.9 to 11.2 | Months | |
| Time to Progression (TTP) | Placebo Tablets of CF102 | 3.3 | Inter-Quartile Range 1.9 to 33.2 | Months | |
| Time to Progression-Free Survival (PFS) | CF102 | 2.5 | Inter-Quartile Range 1.8 to 6.1 | months | |
| Time to Progression-Free Survival (PFS) | Placebo Tablets of CF102 | 1.9 | Inter-Quartile Range 1.8 to 3.8 | months | |
| Objective Response Rate (ORR) | CF102 | Cycle 3 Day 1 | 1 | Participants | |
| Objective Response Rate (ORR) | Placebo Tablets of CF102 | Cycle 3 Day 1 | 0 | Participants | |
| Objective Response Rate (ORR) | CF102 | Cycle 5 Day 1 | 2 | Participants | |
| Objective Response Rate (ORR) | Placebo Tablets of CF102 | Cycle 5 Day 1 | 0 | Participants | |
| Objective Response Rate (ORR) | CF102 | Cycle 7 Day 1 | 2 | Participants | |
| Objective Response Rate (ORR) | Placebo Tablets of CF102 | Cycle 7 Day 1 | 0 | Participants | |
| Objective Response Rate (ORR) | CF102 | Cycle 9 Day 1 | 2 | Participants | |
| Objective Response Rate (ORR) | Placebo Tablets of CF102 | Cycle 9 Day 1 | 0 | Participants | |
| Objective Response Rate (ORR) | CF102 | Cycle 11 Day 1 | 2 | Participants | |
| Objective Response Rate (ORR) | Placebo Tablets of CF102 | Cycle 11 Day 1 | 0 | Participants | |
| Disease Control Rate (DCR) | CF102 | Cycle 3 Day 1 | 19 | Participants | |
| Disease Control Rate (DCR) | Placebo Tablets of CF102 | Cycle 3 Day 1 | 10 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02128958/results